GSK India Unit Expects Benefits From Swap For Novartis Vaccine Portfolio
This article was originally published in PharmAsia News
The trade of businesses GlaxoSmithKline and Novartis made in April, GSK getting a vaccine portfolio, Novartis an oncology business, is expected to rebound in the favor of the U.K.-based drug maker's India unit.
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.